Revision history of "Development of manufacturing technology for a generic drug used in the treatment of hyperuricaemia, based on the active substance in a new polymorphic crystalline form" (Q78856)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 October 2024

  • curprev 05:5405:54, 13 October 2024DG Regio talk contribs 93,971 bytes +5 Changed label, description and/or aliases in pt
  • curprev 05:5405:54, 13 October 2024DG Regio talk contribs 93,966 bytes +9 Set a claim value: summary (P836): Número de referência do programa de ajuda: SA.41471(2015/X) Objetivo do auxílio público: Artigo 25.o do Regulamento (CE) n.o 651/2014, de 17 de junho de 2014, que declara certos tipos de auxílio compatíveis com o mercado interno, em aplicação dos artigos 107.o e 108.o do Tratado (JO L EU L 187/1 de 26.6.2014). Objectivo do Projecto Bn. Desenvolvimento da tecnologia de fabrico de um medicamento genérico utilizado no tratamento da hiperuricemia, com b...

12 March 2024

12 January 2024

14 June 2023

11 June 2023

24 May 2023

2 March 2023

25 October 2022

20 October 2022

5 September 2022

19 January 2022

15 January 2022

16 December 2021

7 December 2021

30 November 2021

  • curprev 14:2514:25, 30 November 2021DG Regio talk contribs 18,590 bytes +3,010 Created claim: summary (P836): Reference_Aid_programme: SA.41471(2015/X) But_public_aid: Article 25 du règlement (CE) no 651/2014 du 17 juin 2014 déclarant certaines catégories d’aides compatibles avec le marché intérieur en application des articles 107 et 108 du traité (JO URZ. EU L 187/1 du 26.6.2014). L’objectif du projet „Développer la technologie de fabrication d’un médicament générique utilisé dans le traitement de l’hyperuricémie, à partir de la substance active...
  • curprev 14:2514:25, 30 November 2021DG Regio talk contribs 15,580 bytes +266 Changed label, description and/or aliases in fr: translated_label

29 October 2020

14 October 2020

  • curprev 10:3110:31, 14 October 2020DG Regio talk contribs 15,754 bytes +227 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 10:3110:31, 14 October 2020DG Regio talk contribs 15,527 bytes −201 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 10:3110:31, 14 October 2020DG Regio talk contribs 15,728 bytes +2,847 Created claim: summary (P836): Reference number of the aid programme: SA.41471(2015/X) Purpose of public aid: Article 25 of EC Regulation No 651/2014 of 17 June 2014 declaring certain types of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L. I'm sorry. EU L 187/1 of 26.06.2014). Aim of Project Bn. Development of the manufacturing technology of a generic drug used in the treatment of hyperuricaemia, based on the active sub...
  • curprev 10:3110:31, 14 October 2020DG Regio talk contribs 12,881 bytes −2,393 Removed claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The objective of the project:& bdn; development of a generic technology for a generic medicinal product used in the treatment of hyperurikemia, which is base...

25 September 2020

23 September 2020

15 July 2020

9 June 2020

6 June 2020

26 March 2020

4 March 2020

  • curprev 09:3109:31, 4 March 2020DG Regio talk contribs 13,562 bytes +2,393 Created claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The objective of the project:& bdn; development of a generic technology for a generic medicinal product used in the treatment of hyperurikemia, which is based...

18 February 2020

8 February 2020

31 January 2020

13 January 2020